Source: The American Journal of Gastroenterology. Unidades: FMRP, FM
Subjects: DOENÇA DE CROHN, EFETIVIDADE, ESTUDOS MULTICÊNTRICOS, ANTICORPOS MONOCLONAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARRA, Rogério Serafim et al. Long-term effectiveness and safety of ustekinumab for the treatment of Crohn´s disease: a brazilian multicentre real-world study. The American Journal of Gastroenterology, v. 115, p. S2, 2020Tradução . . Disponível em: https://doi.org/10.14309/01.ajg.0000722828.45880.db. Acesso em: 18 nov. 2024.APA
Parra, R. S., Chebli, J., Chebli, L., Bertges, E., Ambrogini Junior, O., Schiavetti, B., et al. (2020). Long-term effectiveness and safety of ustekinumab for the treatment of Crohn´s disease: a brazilian multicentre real-world study. The American Journal of Gastroenterology, 115, S2. doi:10.14309/01.ajg.0000722828.45880.dbNLM
Parra RS, Chebli J, Chebli L, Bertges E, Ambrogini Junior O, Schiavetti B, Alves Júnior AJ, Flores C, Lubini M, Gasparetti Junior N, Bafutto M, Azevedo MFC de, Damiao AOMC, Queiroz NSF, Steinwurz F, Carvalho N, Boratto S, Vilela E, Rocha JJR da, Féres O. Long-term effectiveness and safety of ustekinumab for the treatment of Crohn´s disease: a brazilian multicentre real-world study [Internet]. The American Journal of Gastroenterology. 2020 ; 115 S2.[citado 2024 nov. 18 ] Available from: https://doi.org/10.14309/01.ajg.0000722828.45880.dbVancouver
Parra RS, Chebli J, Chebli L, Bertges E, Ambrogini Junior O, Schiavetti B, Alves Júnior AJ, Flores C, Lubini M, Gasparetti Junior N, Bafutto M, Azevedo MFC de, Damiao AOMC, Queiroz NSF, Steinwurz F, Carvalho N, Boratto S, Vilela E, Rocha JJR da, Féres O. Long-term effectiveness and safety of ustekinumab for the treatment of Crohn´s disease: a brazilian multicentre real-world study [Internet]. The American Journal of Gastroenterology. 2020 ; 115 S2.[citado 2024 nov. 18 ] Available from: https://doi.org/10.14309/01.ajg.0000722828.45880.db